Ivermectin gets green light after lobby, but experts await better data sets
Pundits are divided, but the regulatory authority has, with caution, introduced a ‘controlled-access programme’
27 January 2021 - 19:41
Pundits are divided, but the regulatory authority has, with caution, introduced a ‘controlled-access programme’
This article is reserved for Sunday Times subscribers.
A subscription gives you full digital access to all Sunday Times content.
Please visit SundayTimes.co.za in your desktop to view our latest subscription options.
Already subscribed? Simply sign in below.
Sign InQuestions or problems? Email helpdesk@timeslive.co.za or call 0860 52 52 00.